Can co-stimulated tumor immunity be therapeutically efficacious?
Hellström
K E
KE
Bristol-Myers Pharmaceutical Research Institute, Seattle, WA 98121, USA.
Hellström
I
I
Chen
L
L
D000818:Animals; D018122:B7-1 Antigen / Q000494:pharmacology*; D018106:CD28 Antigens / Q000494:pharmacology*; D004357:Drug Synergism; D016233:Immunotherapy, Active; D051379:Mice; D009374:Neoplasms, Experimental / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*
D018122:B7-1 Antigen; D018106:CD28 Antigens